{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:25:54Z","timestamp":1793190354691,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014489","name":"Johnson & Johnson Pharmaceutical Research and Development LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","award":["HHSO100201700018C"],"award-info":[{"award-number":["HHSO100201700018C"]}],"id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ebiom.2025.105809","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T08:12:21Z","timestamp":1749888741000},"page":"105809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-6586","authenticated-orcid":false,"given":"Nina","family":"Hertoghs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Br\u00fcckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerald","family":"Sadoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7332-7117","authenticated-orcid":false,"given":"Barbara L.","family":"Banbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Akers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Howie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan S.","family":"Robins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griet A.","family":"van Roey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen T.B.M.","family":"Tolboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica V.","family":"Rezelj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Schuitemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Stieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Le Gars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ebiom.2025.105809_bib6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMc2108829","article-title":"Durable humoral and cellular immune responses 8 months after Ad26.COV2.S vaccination","volume":"385","author":"Barouch","year":"2021","journal-title":"N Engl J Med"},{"issue":"32","key":"10.1016\/j.ebiom.2025.105809_bib7","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1016\/j.vaccine.2022.05.047","article-title":"Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials","volume":"40","author":"Sadoff","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2025.105809_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/imr.13088","article-title":"Immunogenicity and efficacy of Ad26.COV2.S: an adenoviral vector\u2013based COVID-19 vaccine","volume":"310","author":"Le Gars","year":"2022","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105809_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa2117608","article-title":"Final analysis of efficacy and safety of single-dose Ad26.COV2.S","volume":"386","author":"Sadoff","year":"2022","journal-title":"N Engl J Med"},{"issue":"December","key":"10.1016\/j.ebiom.2025.105809_bib1","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/s41564-022-01262-1","article-title":"Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial","volume":"7","author":"Fong","year":"2022","journal-title":"Nat Microbiol"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105809_bib2","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105809_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00630-0","article-title":"Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine","volume":"8","author":"Benkeser","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"24","key":"10.1016\/j.ebiom.2025.105809_bib4","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMp2211314","article-title":"A covid-19 milestone attained \u2014 a correlate of protection for vaccines","volume":"387","author":"Gilbert","year":"2022","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ebiom.2025.105809_bib9","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat Med"},{"issue":"6576","key":"10.1016\/j.ebiom.2025.105809_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.ebiom.2025.105809_bib11","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 breakthrough infections in vaccinated health care workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N Engl J Med"},{"issue":"32","key":"10.1016\/j.ebiom.2025.105809_bib12","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105809_bib13","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/s41467-023-37176-7","article-title":"Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis","volume":"14","author":"Cromer","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105809_bib14","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1038\/s41467-024-53727-y","article-title":"Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial","volume":"15","author":"Carpp","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105809_bib15","article-title":"Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals","volume":"2","author":"Tarke","year":"2021","journal-title":"Cell Rep Med"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105809_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105809_bib17","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/cid\/ciac353","article-title":"Clinical validation of a novel T-cell receptor sequencing assay for identification of recent or prior severe acute respiratory syndrome coronavirus 2 infection","volume":"75","author":"Dalai","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.ebiom.2025.105809_bib18","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","article-title":"Interim results of a phase 1\u20132a trial of Ad26.COV2.S covid-19 vaccine","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ebiom.2025.105809_bib19","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105809_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-03154-6","article-title":"Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.ebiom.2025.105809_bib21","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2009-04-217604","article-title":"Comprehensive assessment of T-cell receptor \u03b2-chain diversity in \u03b1\u03b2 T cells","volume":"114","author":"Robins","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2025.105809_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3680","article-title":"Using synthetic templates to design an unbiased multiplex PCR assay","volume":"4","author":"Carlson","year":"2013","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2025.105809_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jim.2011.09.001","article-title":"Ultra-sensitive detection of rare T cell clones","volume":"375","author":"Robins","year":"2012","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ebiom.2025.105809_bib24","article-title":"Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels","author":"Snyder","year":"2020","journal-title":"medRxiv"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105809_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150070","article-title":"T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity","volume":"7","author":"Elyanow","year":"2022","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105809_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144930","article-title":"Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates","volume":"131","author":"Boonyaratanakornkit","year":"2021","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105809_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141561","article-title":"Multiplex identification of antigen-specific T cell receptors using a combination of immune assays and immune receptor sequencing","volume":"10","author":"Klinger","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ebiom.2025.105809_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151849","article-title":"Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection","volume":"7","author":"Gittelman","year":"2022","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.ebiom.2025.105809_bib29","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1128\/JVI.03474-14","article-title":"Dynamics of the cytotoxic T cell response to a model of acute viral infection","volume":"89","author":"DeWitt","year":"2015","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105809_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1214\/08-AOAS194","article-title":"A simple forward selection procedure based on false discovery rate control","volume":"3","author":"Benjamini","year":"2009","journal-title":"Ann Appl Stat"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105809_bib31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/biostatistics\/kxac024","article-title":"A controlled effects approach to assessing immune correlates of protection","volume":"24","author":"Gilbert","year":"2023","journal-title":"Biostatistics"},{"key":"10.1016\/j.ebiom.2025.105809_bib32","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T follicular helper cell biology: a decade of discovery and diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"issue":"71","key":"10.1016\/j.ebiom.2025.105809_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo1303","article-title":"Understanding T-cell responses to COVID-19 is essential for informing public health strategies","volume":"7","author":"Vardhana","year":"2022","journal-title":"Sci Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105809_bib34","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.01281-09","article-title":"Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4 + T cells are important in control of SARS-CoV infection","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105809_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMc2119641","article-title":"Plasma neutralization of the SARS-CoV-2 omicron variant","volume":"386","author":"Schmidt","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105809_bib36","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41591-022-01753-y","article-title":"Effectiveness of mRNA-1273 against SARS-CoV-2 omicron and delta variants","volume":"28","author":"Tseng","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2025.105809_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.797589","article-title":"Neutralization of SARS-CoV-2 variants by mRNA and adenoviral vector vaccine-elicited antibodies","volume":"13","author":"Tada","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105809_bib38","first-page":"1205","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021"},{"issue":"9","key":"10.1016\/j.ebiom.2025.105809_bib39","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105809_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41577-022-00716-1","article-title":"Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?","volume":"22","author":"Kent","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"52","key":"10.1016\/j.ebiom.2025.105809_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients","volume":"5","author":"Isho","year":"2020","journal-title":"Sci Immunol"},{"issue":"7847","key":"10.1016\/j.ebiom.2025.105809_bib42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ebiom.2025.105809_bib43","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2025.105809_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31721-6","article-title":"A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection","volume":"13","author":"Pardieck","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ebiom.2025.105809_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105809_bib46","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","article-title":"Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity","volume":"183","author":"Rydyznski Moderbacher","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2025.105809_bib47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/v15030709","article-title":"T cell responses correlate with self-reported disease severity and neutralizing antibody responses predict protection against SARS-CoV-2 breakthrough infection","volume":"15","author":"Zhao","year":"2023","journal-title":"Viruses"},{"issue":"61","key":"10.1016\/j.ebiom.2025.105809_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg5669","article-title":"CD8+T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients","volume":"6","author":"Mallajosyula","year":"2021","journal-title":"Sci Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2025.105809_bib49","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202187","article-title":"Mapping and role of T cell response in SARS-CoV-2-infected mice","volume":"218","author":"Zhuang","year":"2021","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.ebiom.2025.105809_bib50","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-021-01386-7","article-title":"CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer","volume":"27","author":"Bange","year":"2021","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2025.105809_bib51","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/s41564-022-01262-1","article-title":"Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial","volume":"7","author":"Fong","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ebiom.2025.105809_bib52","series-title":"Advances in immunology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ai.2023.01.001","article-title":"Antigen receptor structure and signaling","author":"Han","year":"2023"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425002531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425002531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:16:28Z","timestamp":1762618588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425002531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":52,"alternative-id":["S2352396425002531"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105809","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105809"}}